Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tony Goodman currently holds 42,000 shares of ADIAL PHARMACEUTICALS, INC. (ADIL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tony Goodman has been a net neutral trader of ADIL stock. They have purchased $0 and sold $0 worth of shares.
Tony Goodman's most recent insider trade was on Mar 25, 2024, when they sold 42,000 shares at $0.00 per share.
Tony Goodman serves as Executive at ADIAL PHARMACEUTICALS, INC. (ADIL). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Tony Goodman holds the position of Executive at ADIAL PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Tony Goodman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Tony Goodman was on Mar 25, 2024, when they purchased $0 worth of ADIL shares. This transaction involved 42,000 shares at N/A per share.
Tony Goodman currently owns 42,000 shares of ADIAL PHARMACEUTICALS, INC. (ADIL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tony Goodman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tony Goodman has 2 Form 4 filings on record as an insider at ADIAL PHARMACEUTICALS, INC..
Set alerts for Tony Goodman and 40,000+ other insiders.